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Acovulparine (1,6,7R,8,14,16)-4-(hydroxymethyl)-1,6,14,16-tetramethoxyaconit-19-ene-7,8-diol;
1), a new norditerpene alkaloid, was isolated from the MeOH extract of the whole plants of Aconitum
vulparia R., together with the known compounds lycoctonine (2) and delcosine (3). The structures
were established by HR-EI-MS and advanced 2D-NMR, including 1H-NMR, JMOD, 1H,1H-COSY, HSQC, and
HMBC experiments. Acovulparine was found to contain the rare C(19)N azomethine group.
Introduction. ± Aconitum species accumulate highly toxic diterpene and norditer-
pene alkaloids that have attracted considerable interest because of their complex
structures, interesting chemistry, and noteworthy physiological effects [1]. Previous
pharmacological studies of these compounds have focused mainly on their powerful
anti-arrhythmic, anti-epileptic, and antinociceptive activities, which are due to their
interactions with voltage-gated Na channels [2]. Different types of norditerpene
alkaloids have been reported either as agonists (e.g., aconitine and mesaconitine) or
antagonists (e.g., lappaconitine 6-benzoyllappaconitine) of Na channels [3]. More-
over, recent investigations of some norditerpene alkaloids have revealed that they exert
selective antagonistic activity in nanomolar concentration on the neuronal nicotinic
acetylcholine (nACh) receptor. Such compounds, e.g., methyllycaconitine, are valuable
neurobiological tools to study the nACh receptor. Also, methyllycaconitine is a lead
compound for the treatment of Alzheimer×s disease [4].
As a continuation of our ongoing studies on biologically active compounds from
Hungarian Ranunculaceae species, the alkaloidal constituents of Aconitum vulparia
R. were studied. A. vulparia is a perennial plant with stout leafy stems and
yellowish flowers that occurs in many European countries [5]. The present paper
reports the isolation and structure elucidation of a new norditerpene alkaloid, named
acovulparine (1), together with the known compounds lycoctonine (2) and delcosine
(3). The structures were determined spectroscopically, and previously unpublished
NMR spectral data on lycoctonine are also presented.
Results and Discussion. ± Dried whole plants of A. vulparia were extracted with
MeOH. The extract was subjected to solvent partitioning and then to multiple
chromatographic separations, affording compounds 1 ± 3.
Compound 1was isolated as an amorphous solid, with []29D 25.3 (c 2, CHCl3).
HR-EI-MS established the molecular formula C23H35NO7, with the M signal at m/z
437.2396 (calc. 437.2414). From the 1H-NMR and JMOD (J-modulated spin-echo
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experiment) spectra of 1, four MeO groups were identified ((H) 3.16, 3.36, 3.42, 3.44
(4s); (C) 56.1, 56.2, 57.7, 58.4). The signals at (H) 7.46 (s) and (C) 166.9 suggested
the presence of an azomethine group instead of the N-Et or N-Me group characteristic
of many norditerpenoid alkaloids [6] [7]. The HSQC spectrum of 1 revealed a C19
norditerpene skeleton composed of five CH2, four oxygenated and five alkyl-
substituted CH groups, and two oxygenated and two alkyl-substituted quaternary C-
atoms (Table).
Table. NMR Data of Acovulparine (1). In CDCl3 at 500 (1H) and 125 (13C) MHz, resp.;  in ppm, J in Hz.
Position 1H 13C HMBC (CH) 1H,1H-COSYa) NOESYa)
1 3.24 (t, J 3.8) 81.6 1-MeO, 2, 3, 3 2, 2 2, 10, 1-MeO
2 1.71 (m) 20.9 3 1, 2, 3, 3 ±
2 1.42 (m) 1, 2, 3 1, 5
3 1.73 (m) 24.2 1, 2, 2, 18a, 18b 2, 3 ±
3 1.64 (m) 2, 2, 3 5
4 ± 48.2 2, 3, 3, 6, 18a, 18b, 19 ± ±
5 1.80 (s) 45.4 1, 6, 18a, 18b, 19 6, 17b), 19b) 2, 3, 6-MeO
6 3.88 (br. s) 90.8 5, 17, 6-MeO 5 5, 18a, 6-MeO
7 ± 86.5 5, 6, 14c), 15, 15, 17 ± ±
8 ± 77.2 6, 9, 10, 14, 15, 15, 17 ± ±
9 2.85 (t, J 5.5) 42.9 10, 13, 14, 15 10, 13b), 14 10, 14, 16-MeO
10 1.99 (m) 43.4 1, 9, 12, 12, 13 9, 12, 12 1, 9
11 ± 50.4 1, 5, 6, 10, 12 ± ±
12 2.03 (m) 30.2 9, 10, 13, 16 10, 12, 13 12, 13
12 1.48 (dd, J 13.0, 4.4) 10, 12 12, 16, 17
13 2.41 (dd, J 6.5, 4.4) 37.9 9, 12, 12, 14, 15 9b), 12, 14 12, 14, 16-MeO
14 3.66 (t, J 4.4) 84.1 9, 12, 13, 16, 14-MeO 9, 13, 16b) 9, 13, 16-MeO
15 2.80 (dd, J 15.0, 8.5) 33.1 9, 13 15, 16 15, 16
15 1.70 (m) 15, 16 15
16 3.27 (t, J 8.5) 82.5 12, 12, 13, 14, 15, 15, 16-MeO 14b), 15, 15 12, 15
17 3.76 (br. s) 64.4 1, 5, 10 5b) 12
18a 3.81 (d, J 10.8) 64.3 5 18b 6
18b 3.77 (d, J 10.8) 18a, 19b) ±
19 7.46 (br. s) 166.9 3, 5, 17, 18 5b), 18bb) ±
1-MeO 3.16 (s) 56.1 1 ± 1
6-MeO 3.44 (s) 58.4 6 ± 5, 6
14-MeO 3.42 (s) 57.7 14 ± ±
16-MeO 3.36 (s) 56.2 16 ± 9, 13, 14
a) Position of H-atoms. b) 4J(H,H) coupling. c) 4J(C,H) coupling.
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The 1H,1H-COSY correlations between (H) 3.24 (HC(1)) and 1.71/1.42
(CH2(2)) and between (H) 1.42 and 1.64 (HbC(2) and HbC(3)) indicated a
CHRCH2CH2 structural element (fragment A; see Figure below). This fragment
was identified as the C(1) ±C(3) part of the molecule, because correlations were
observed between HC(1) and C(11), between HaC(2) and C(4), and between
CH2(3) and C(4) in the HMBC spectrum of 1. Further, HMBC correlations were
detected between C(4) and the azomethine H-atom (HC(19)), confirming the
position of the C(19)N azomethine group.
The correlation between the signals at (H) 1.80 and 3.88 in the 1H,1H-COSY
spectrum established the presence of a CHCH structural moiety (fragment B) in 1.
For identification of this fragment, W-type 4J(H,H) correlations between HC(5) and
HC(19), and between HC(5) and HC(17) in the 1H,1H-COSY spectrum, and
HMBC cross-peaks between C(4) and HC(6), C(11) and HC(5), and C(11) and
HC(6), were informative, revealing that fragment B corresponds to the C(5)C(6)
part of the norditerpene core. An isolated CH2 group was detected at (H) 3.81 and
3.77, and assigned as CH2(18), since these signals demonstrated long-range 1H,13C
correlations with C(3), C(4) and C(5), respectively. An isolated CH group at (H) 3.76
(br. s) was identified as HC(17) through its long-range couplings with C(6), C(19),
and the quaternary C-atoms C(7) and C(8). The HMBC cross-peak of HC(5) and
C(7) ((C) 86.5) allowed distinction of C(7) and C(8).
The structure of 1was further elucidated with the aid of the 1H,1H-COSY spectrum,
from which a five-membered ring, i.e., a CHCHCH2CHCHOR (RH or Me)
sequence was derived (fragment C). This unit was assigned as the
C(9)C(10)C(12)C(13)C(14) part of compound 1 on the basis of HMBC
correlations of C(8) with HC(9), HC(10) and HC(14), and the cross-peaks of
C(11) with HC(10) and HC(12). The fourth structural element identified from the
1H,1H-COSY spectrum was a CH2CH unit (fragment D), which was identified as
CH2(15)CH(16) from the 4J(H,H) couplings of HC(14) and HC(16), and from
the heteronuclear long-range correlations between C(8) and HC(15), C(12) and
HC(16), and C(14) and HC(16) (Figure).
Figure. Selected 1H,1H-COSY () and HMBC (CH) correlations for acovulparine (1)
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The four MeO groups were located at C(1), C(6), C(14), and C(16), respectively, as
determined from the HMBC cross-peaks between the MeO C-atoms ((C) 56.1, 58.4,
57.7, 56.2) and HC(1), HC(6), HC(14), and HC(16), respectively.
The relative configurations of the stereogenic centers were assigned by means of
nuclear-Overhauser-enhancement spectroscopy (NOESY). In the NOESY spectrum
of 1, correlations were detected between HC(1) and HC(10), HC(10) and
HC(9), HC(9) and HC(14), HC(14) and HC(13), HC(1) and HC(2),
and HC(2) and HC(5), all indicating -oriented H-atoms. Further, the NOESY
correlations of MeOC(16) with HC(9), HC(13), and HC(14), respectively, also
demonstrated the -position of these H-atoms and the MeO group. A J(5,6) value of
0 Hz dictated the -orientation of HC(6) [7 ± 9]. Further important NOEs were
observed between HC(12) and HC(17), leading to the conclusion that the
CHNCH bridge (C(19)NC(17)) is oriented below the plane of rings A and B.
NOESY Cross-peaks between HC(12) and HC(13), HC(12) and HC(16),
HC(3) andHC(6), andHC(15) andHC(16) led to the steric differentiation of
CH2(12), CH2(3), and CH2(15), as listed in the Table. All of the above data led to the
structural assignment of acovulparine (1) as (1,6,7R,8,14,16)-4-(hydroxymethyl)-
1,6,14,16-tetramethoxyaconit-19-ene-7,8-diol.
The known alkaloids lycoctonine (2) and delcosine (3) were also isolated from A.
vulparia, and identified by means of NMR. As a result of 1H-NMR, JMOD, 1H,1H-
COSY, NOESY, HSQC, and HMBC experiments, complete chemical-shift assignments
for all 1H- and 13C-NMR resonances of 2 were achieved, and the previously published
NMR data [10] were supplemented (see the Exper. Part). Delcosine (3) was identified
by comparing its spectral data with those reported in the literature, and by TLC co-
chromatography with an authentic sample [6] [11].
Conclusions. ± From A. vulparia, a new aconitene alkaloid named acovulparine (1)
was identified, together with lycoctonine (2) and delcosine (3). The isolated
compounds are biogenetically related: 1 and 2 differ only with respect to the N-
function (azomethine vs. N-Et group, respectively). Delcosine (3) is also a compound
of the lycoctonine type, but with a dissimilar methylation pattern. Lycoctonine (2) had
been isolated earlier from the seeds and roots of A. vulparia (syn. A. lycoctonum ssp.
lycoctonum) [12], but this is the first report of delcosine (3) from this plant species.
Experimental Part
General. For vacuum liquid chromatography (VLC), silica gel (Kieselgel GF254, 15 m;Merck) and Al2O3
(Aluminiumoxid G (Typ E) ; Merck) were used. For gel chromatography, Sephadex LH-20 (Pharmacia LKB)
was applied. Prep. TLC was carried out on Kieselgel 60F254 (Merck) and on Aluminiumoxid 60F254 (Merck)
plates. Chromatographic fractions were monitored by TLC on silica-gel plates (Merck 5715), visualized by
spraying with Dragendorff reagent or conc. H2SO4, followed by heating. Optical rotations: Perkin-Elmer 341
polarimeter. NMR spectra: in CDCl3 on a Bruker Avance DRX-500 spectrometer at 500 MHz (1H) or 125 MHz
(13C); chemical shifts  in ppm rel. to residual solvent signals (CHCl3), J in Hz. 2D-NMR Data were acquired
and processed with standard Bruker software. In the 1H,1H-COSY, HSQC, and HMBC experiments, gradient-
enhanced versions were used. HR-EI-MS: Finnigan MAT 95 S ; in m/z (rel. %).
Plant Material. Aconitum vulparia R. was collected from wild stock growing in the region of
Nagyva¬zsony, Hungary, in September 2002. The plant was identified by Andra¬s Me¬sza¬ros, Balaton Uplands
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National Park, Veszpre¬m, Hungary. A voucher specimen (No. 617) has been deposited in the Herbarium of the
Department of Pharmacognosy, University of Szeged, Szeged, Hungary.
Extraction and Isolation. Dried, ground whole plants of A. vulparia (250 g) were crushed in a blender and
then extracted exhaustively with MeOH (12 l). After evaporation, the crude extract was dissolved in 4% aq.
H2SO4 (250 ml) and extracted exhaustively with CHCl3. The org. layer was extracted with 2% aq. H2SO4. The
aq. phase was then rendered alkaline with 5% aq. NaOH soln., and extracted with CHCl3. The CHCl3 phase was
evaporated under reduced pressure, and separated by VLC (Al2O3; hexane/AcOEt/MeOH 50 :50 : 0.5, 50 : 50 :1,
50 : 50 : 1.5, 50 : 50 :2, 50 : 50 : 3, 50 :50 : 4, 50 :50 :5, 50 :50 :10, and 1 :1 :1). The fractions obtained by eluting with
the above solvent systems 50 :50 :3 and 50 :50 : 4 were further fractionated by VLC (SiO2; cyclohexane/CHCl3/
MeOH mixtures of increasing polarity). The subfractions eluted with the systems 50 :50 : 6 and 50 :50 : 8 were
repeatedly purified by VLC (Al2O3; cyclohexane/CHCl3/MeOH 50 :50 : 2, 50 :50 :4, 50 : 50 : 7, 50 : 50 : 10, and
50 :50 : 20). The fraction eluted with the solvent system 50 :50 : 3 was subjected to gel chromatography
(Sephadex LH-20 ; MeOH): 27 1-ml fractions (Fr.), from which Fr. 16 ± 18 afforded compound 1 (36 mg). The
fraction obtained from the first VLC (Al2O3; cyclohexane/CHCl3/MeOH 50 :50 :1) was purified first by prep.
TLC (Al2O3; cyclohexane/CHCl3/MeOH 50 :50 : 10), and then by gel chromatography (Sephadex LH-20 ;
MeOH). Fr. 12 and 13 from gel chromatography were further purified by prep. TLC (Al2O3; hexane/AcOEt/
MeOH 50 :50 :4), which yielded compound 2 (10 mg). Compound 3 was isolated from the CHCl3 phase
obtained from the alkaline soln. of the crude MeOH extract. The CHCl3 phase was subjected first to VLC
(Al2O3; gradient of hexane/AcOEt/MeOH 50 :50 :1, 50 :50 : 1.5, 50 : 50 : 2, 50 : 50 : 3, 50 : 50:4, 50 :50 : 5, and
50 :50 : 10), and then purified by prep. TLC (SiO2; toluene/acetone/EtOH/NH3 70 :50 : 35 :6), which furnished
compound 3 (20 mg).
(1,6,7R,8,14,16)-4-(Hydroxymethyl)-1,6,14,16-tetramethoxyaconit-19-ene-7,8-diol (Acovulparine ;
1). Amorphous solid. []29D 25.3 (c 2, CHCl3). 1H- and 13C-NMR: see the Table. HR-EI-MS: 437.23958
(36, M, C23H35NO7 ; calc. 437.24135), 422 (90, [MMe]), 406 (100, [MMeO]).
Lycoctonine (2). Colorless crystals. M.p. 110 ± 113. []29D 56 (c 0.05, CHCl3). 1H-NMR (500 MHz,
CDCl3): 4.04 (s, 8-OH); 3.85 (s, HC(6)); 3.64 (d, J 10.6, HaC(18)); 3.60 (t, J 5.0, HC(14)); 3.44 (s, 6-
MeO); 3.41 (s, 14-MeO); 3.36 (d, J 10.6, HbC(18)); 3.34 (s, 16-MeO); 3.25 (s, 1-MeO); 3.21 (t, J 8.5, 7.7,
HC(16)); 3.07 (t, J 5.9, 5.0, HC(9)); 2.94 (m, HC(1)); 2.93 (m, HaC(20)); 2.91 (s, HC(17)); 2.79
(dq, J 12.9, 7.0, HbC(20)); 2.59 (d, J 12.0, HaC(19)); 2.58 (dd, J 15.3, 8.5, HaC(15)); 2.44 (dd, J 14.3,
4.8, HaC(12)); 2.33 (dd, J 6.9, 4.8, HC(13)); 2.28 (d, J 12.0, HbC(19)); 2.15 (m, HC(2)); 2.08
(m, HC(2)); 1.90 (m, HC(10)); 1.84 (m, HbC(12)); 1.69 (s, HC(5)); 1.66 (m, HbC(15)); 1.66
(m, HaC(3)); 1.49 (m, HbC(3)); 1.04 (t, J 7.0, Me(21)). 13C-NMR (125 MHz, CDCl3): 90.8 (C(6)); 88.5
(C(7)); 84.3 (C(1)); 84.0 (C(14)); 82.7 (C(16)); 77.5 (C(8)); 68.0 (C(18)); 64.8 (C(17)); 57.9 (6-MeO); 57.8 (14-
MeO); 56.2 (16-MeO); 55.7 (1-MeO); 52.7 (C(19)); 51.1 (C(20)); 49.8 (C(5)); 49.0 (C(11)); 46.3 (C(10)); 43.4
(C(9)); 38.6 (C(4)); 38.2 (C(13)); 33.7 (C(15)); 31.7 (C(3)); 28.8 (C(12)); 26.2 (C(2)); 14.1 (C(21)).
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